NADAL
DEAD

Serial Number

79296387

Owner

nal von minden GmbH

Attorney

Christopher J. Voci

Filing Date

Jul 28, 2020

Add to watchlist:

No watchlists yet
View on USPTO

NADAL Trademark

Serial Number: 79296387

NADAL is a trademark filed by nal von minden GmbH on July 28, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

nal von minden GmbH (5 trademarks)

Carl-Zeiss-Straße 12

Entity Type: 27

Trademark Details

Filing Date

July 28, 2020

Registration Date

Not Registered

Goods & Services

Diagnostic and analysis agents, preparations and reagents for medical and veterinary purposes, namely, for testing of allergies, autoimmunity diseases, presence of bacteria, diabetes, blood glucose levels, inflammation, fertility or infertility, pregnancy, sexually transmitted diseases, urinary tract infections, cancer, hormonal disorders, immune status, presence of fungi, presence of viral markers, infectious diseases, food intolerances, kidney dysfunction, liver dysfunction, thyroid gland dysfunction, cardiovascular dysfunction, or metabolic dysfunction; test strips for medical and veterinary purposes for testing the presence of allergies, autoimmunity markers, bacteria, fungi, viral markers, diabetes markers, inflammation markers, fertility hormones, pregnancy hormones, fertility markers, markers for sexually transmitted diseases, markers for urinary tract infections, markers for infectious diseases, endocrinology markers, metabolic markers, tumor markers, hormones, blood markers, markers for food intolerances, markers for kidney dysfunction, markers for liver dysfunction, markers for thyroid gland dysfunction, markers for cardiovascular dysfunction or markers for metabolic dysfunction, for testing immune status, urine, or blood glucose levels; immunological quick tests for instant diagnostics; medical diagnostic preparations, in particular diagnostic quick tests, for use in the fields of infectology, pediatrics, gynecology, bacteriology, urology, latex agglutination, cardiology, oncology and drug analysis; reagents for use in diagnostic pregnancy tests; reagents for use in ovulation tests for medical purposes; reagents for use in diagnostic HIV tests; reagents for use in drug tests for medical purposes; myocardial infarction markers; diagnostic agents and preparations in the nature of test stripes, test cassettes, multi-line tests, test liquids, ELISA tests, EIAs (enzyme immuno assays), or dry chemistry assay kits for detecting infectious diseases

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 19, 2023 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Jun 1, 2023 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 1, 2023 FICR
ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Jun 1, 2022 MAB3
ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Jun 1, 2022 MAB3
ABANDONMENT - AFTER EX PARTE APPEAL
Jun 1, 2022 ABN3
EXPARTE APPEAL TERMINATED
Jun 1, 2022 EXPT
EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
Apr 19, 2022 EXFB
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 17, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 27, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 23, 2022 OPNR
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Feb 1, 2022 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Feb 1, 2022 GECD
ACTION CONTINUING FINAL - COMPLETED
Feb 1, 2022 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 7, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 7, 2022 CRFA
ASSIGNED TO LIE
Jan 6, 2022 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 4, 2022 ERFR
EX PARTE APPEAL-INSTITUTED
Jan 4, 2022 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jan 4, 2022 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Jan 4, 2022 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 21, 2021 GNFN
FINAL REFUSAL E-MAILED
Jul 21, 2021 GNFR
FINAL REFUSAL WRITTEN
Jul 21, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 8, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 8, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 8, 2021 TROA
REFUSAL PROCESSED BY IB
Dec 27, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 9, 2020 RFCS
REFUSAL PROCESSED BY MPU
Dec 9, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 21, 2020 RFCR
NON-FINAL ACTION WRITTEN
Nov 20, 2020 CNRT
ASSIGNED TO EXAMINER
Nov 16, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 30, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 26, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 22, 2020 REPR